Effects of Tamoxifen and Raloxifene on Memory and Other Cognitive Abilities: Cognition in the Study of Tamoxifen and Raloxifene

J Clin Oncol. 2009 Sept 21; Epub ahead of print, C Legault, PM Maki, SM Resnick, L Coker, P Hogan, TB Bevers, SA Shumaker

TAKE-HOME MESSAGE

Abstract

SUMMARY

OncologySTAT Editorial Team

Demonstration that tamoxifen and raloxifene are similarly effective in reducing the risk of invasive breast cancer shifts the focus in choosing between the 2 drugs to differences in their adverse effects. One area of concern is the potential for cognitive impairment from treatment with these drugs. The effect of tamoxifen on cognitive function has not been well studied, however, and the effect of raloxifene on cognitive function is unclear. Some small studies with raloxifene have reported little...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

About Our Journal Scans

View a list of journals that the OncologySTAT editorial team scans every week in order to bring you the most practice-relevant original research and review articles.

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration